AT2 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Atara Biotherapeutics Inc

Watchlist Manager

Watchlist

Price: 8.7975 EUR

Market Cap: €19.7B

A	Atara Biotherapeutics Inc SWB:AT2	US
	Schindler Holding AG SIX:SCHP	CH
	National Vision Holdings Inc NASDAQ:EYE	US
	LVMH Moet Hennessy Louis Vuitton SE F:MOH	FR

Profitability Summary

Atara Biotherapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

82%

Strong 3Y Average Gross Margin

54%

Gross Margin is Increasing

-14% > 82%

Exceptional Operating Margin

44%

Negative 3Y Average Operating Margin

-1 357%

Operating Margin is Increasing

-4 375% > 44%

Healthy Net Margin

27%

Negative 3Y Average Net Margin

-1 378%

Net Margin is Increasing

-4 433% > 27%

Negative Free Cash Flow Margin

-42%

Negative 3Y Average Free Cash Flow Margin

-987%

Free Cash Flow Margin is Increasing

-3 118% > -42%

Negative ROE

-48%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-116%

ROIC is Increasing

-333% > 142%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.